Leucine-rich α2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series
Sign Up to like & getrecommendations! Published in 2017 at "Modern Rheumatology"
DOI: 10.1080/14397595.2016.1270795
Abstract: Abstract Objectives: To assess the role of leucine-rich α2-glycoprotein (LRG) as a biomarker for monitoring systemic juvenile idiopathic arthritis (s-JIA) disease activity during interleukin (IL)-6 blockade treatment. Methods: We serially measured serum LRG levels in… read more here.
Keywords: lrg levels; serum lrg; blockade; disease ... See more keywords
Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson’s disease
Sign Up to like & getrecommendations! Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0282153
Abstract: There is ample epidemiological and animal-model evidence suggesting that intestinal inflammation is associated with the development of Parkinson’s disease (PD). Leucine-rich α2 glycoprotein (LRG) is a serum inflammatory biomarker used to monitor the activity of… read more here.
Keywords: lrg levels; serum; serum lrg; biomarker systemic ... See more keywords